APA (7th ed.) Citation

L, M., J, N., F, T., HN, B., E, C., B, J., . . . T, J. (2021). Cytomegalovirus disease in de novo kidney-transplant recipients: Comparison of everolimus-based immunosuppression without prophylaxis with mycophenolic acid-based immunosuppression with prophylaxis. International urology and nephrology, 53(3), 591. https://doi.org/10.1007/s11255-020-02676-8

Chicago Style (17th ed.) Citation

L, Manière, et al. "Cytomegalovirus Disease in De Novo Kidney-transplant Recipients: Comparison of Everolimus-based Immunosuppression Without Prophylaxis with Mycophenolic Acid-based Immunosuppression with Prophylaxis." International Urology and Nephrology 53, no. 3 (2021): 591. https://doi.org/10.1007/s11255-020-02676-8.

MLA (9th ed.) Citation

L, Manière, et al. "Cytomegalovirus Disease in De Novo Kidney-transplant Recipients: Comparison of Everolimus-based Immunosuppression Without Prophylaxis with Mycophenolic Acid-based Immunosuppression with Prophylaxis." International Urology and Nephrology, vol. 53, no. 3, 2021, p. 591, https://doi.org/10.1007/s11255-020-02676-8.